Artis BioSolutions joins a host of startups trying to improve development and manufacturing capacity for cutting-edge gene and cell therapies.
In a new paper published in the journal Trends in Genetics researchers from the University of Vermont and Trinity College ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback